Novartis
NOVN
Delayed Swiss Exchange - 10/20 05:30:07 pm
84.45CHF
+0.12%
Prev.84.3500
Open84.6000
High84.7000
Low83.9500
Volume3 754 156
Last news
Financials
Sales 2017 48 864 M
EBIT 2017 11 614 M
R. net 2017 7 295 M
Debt 2017 17 700 M
Rend. 2017 3,32%
P/E ratio 2017 24,53
P/E ratio 2018 21,59
EV / Sales 2017 5,00x
EV / Sales 2018 4,78x
Capitalization 226 B
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, and Corporate Activities.The Pharmaceuticals segment provides patent-protected prescription medicines.The Alcon segment offers surgical, ophthalmic...
Sector :
Pharmaceuticals - NEC
Calendar :
2017-10-24 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance84,784,790,8
Spread/Res.-0,24%-0,24%-7,0%
Spread/Supp.1,2%4,4%10%
Support83,580,976,6